These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hydroxysafflor yellow A ameliorates alcohol-induced liver injury through PI3K/Akt and STAT3/NF-κB signaling pathways. Wang W; Liu M; Fu X; Qi M; Zhu F; Fan F; Wang Y; Zhang K; Chu S Phytomedicine; 2024 Sep; 132():155814. PubMed ID: 38878526 [TBL] [Abstract][Full Text] [Related]
3. Hydroxysafflor yellows alleviate thrombosis and acetaminophen-induced toxicity in vivo by enhancing blood circulation and poison excretion. Wang LW; Cui XY; He JF; Duan S; Liu CR; Shan CB; Wang Y; Ma CM Phytomedicine; 2021 Jul; 87():153579. PubMed ID: 33991865 [TBL] [Abstract][Full Text] [Related]
4. Hydroxysafflor yellow A exerts anti-fibrotic and anti-angiogenic effects through miR-29a-3p/PDGFRB axis in liver fibrosis. Xue X; Li Y; Zhang S; Yao Y; Peng C; Li Y Phytomedicine; 2024 Sep; 132():155830. PubMed ID: 38959553 [TBL] [Abstract][Full Text] [Related]
5. Integrating Network Pharmacology and Transcriptomic Strategies to Explore the Pharmacological Mechanism of Hydroxysafflor Yellow A in Delaying Liver Aging. Kong J; Sun S; Min F; Hu X; Zhang Y; Cheng Y; Li H; Wang X; Liu X Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430769 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological Actions, Molecular Mechanisms, Pharmacokinetic Progressions, and Clinical Applications of Hydroxysafflor Yellow A in Antidiabetic Research. Zhang X; Shen D; Feng Y; Li Y; Liao H J Immunol Res; 2021; 2021():4560012. PubMed ID: 34938814 [TBL] [Abstract][Full Text] [Related]
7. Hepatoprotective effects of hydroxysafflor yellow A in D-galactose-treated aging mice. Min F; Sun H; Wang B; Ahmad N; Guo H; Gao H; Gao Y; Liu X; Li H Eur J Pharmacol; 2020 Aug; 881():173214. PubMed ID: 32454116 [TBL] [Abstract][Full Text] [Related]
8. Restorative effects of hydroxysafflor yellow A on hepatic function in an experimental regression model of hepatic fibrosis induced by carbon tetrachloride. Li Y; Shi Y; Sun Y; Liu L; Bai X; Wang D; Li H Mol Med Rep; 2017 Jan; 15(1):47-56. PubMed ID: 27909717 [TBL] [Abstract][Full Text] [Related]
9. Hydroxysafflor Yellow A of Carthamus Tinctorius L., Represses the Malignant Development of Esophageal Cancer Cells via Regulating NF-κB Signaling Pathway. Chen X; Wang Y; Zhang L; Gao Y Cell Biochem Biophys; 2020 Dec; 78(4):511-520. PubMed ID: 32705535 [TBL] [Abstract][Full Text] [Related]
10. Protective effects of hydroxysafflor yellow A (HSYA) on alcohol-induced liver injury in rats. He Y; Liu Q; Li Y; Yang X; Wang W; Li T; Zhang W; Cui Y; Wang C; Lin R J Physiol Biochem; 2015 Mar; 71(1):69-78. PubMed ID: 25626885 [TBL] [Abstract][Full Text] [Related]
11. Hydroxysafflor yellow A, a natural compound from Carthamus tinctorius L with good effect of alleviating atherosclerosis. Xue X; Deng Y; Wang J; Zhou M; Liao L; Wang C; Peng C; Li Y Phytomedicine; 2021 Oct; 91():153694. PubMed ID: 34403879 [TBL] [Abstract][Full Text] [Related]
12. Activation of PPARγ is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress. Wang CY; Liu Q; Huang QX; Liu JT; He YH; Lu JJ; Bai XY Phytomedicine; 2013 May; 20(7):592-9. PubMed ID: 23523101 [TBL] [Abstract][Full Text] [Related]
13. The activation of the HIF-1α-VEGFA-Notch1 signaling pathway by Hydroxysafflor yellow A promotes angiogenesis and reduces myocardial ischemia-reperfusion injury. Ge C; Meng D; Peng Y; Huang P; Wang N; Zhou X; Chang D Int Immunopharmacol; 2024 Dec; 142(Pt A):113097. PubMed ID: 39260311 [TBL] [Abstract][Full Text] [Related]
14. Hydroxysafflor yellow A cardioprotection in ischemia-reperfusion (I/R) injury mainly via Akt/hexokinase II independent of ERK/GSK-3β pathway. Min J; Wei C Biomed Pharmacother; 2017 Mar; 87():419-426. PubMed ID: 28068632 [TBL] [Abstract][Full Text] [Related]
15. The anti-anaphylactoid effects of hydroxysafflor yellow A on the suppression of mast cell Ca Liu R; Zhao T; Che D; Cao J; Wang J; Lv Y; Ma P; Ding Y; Wang N; Wang X; Wang N; Wang J; Gao Z; Zhang T Phytomedicine; 2018 Sep; 48():43-50. PubMed ID: 30195879 [TBL] [Abstract][Full Text] [Related]
16. Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation. Jiang S; Shi Z; Li C; Ma C; Bai X; Wang C Int J Clin Exp Pathol; 2014; 7(5):2595-608. PubMed ID: 24966974 [TBL] [Abstract][Full Text] [Related]
17. Protective Effect of Hydroxysafflor Yellow A on Nephropathy by Attenuating Oxidative Stress and Inhibiting Apoptosis in Induced Type 2 Diabetes in Rat. Lee M; Zhao H; Liu X; Liu D; Chen J; Li Z; Chu S; Kou X; Liao S; Deng Y; Li H; Xie W Oxid Med Cell Longev; 2020; 2020():7805393. PubMed ID: 32256962 [TBL] [Abstract][Full Text] [Related]
18. Hydroxy-Safflower Yellow A Mitigates Vascular Remodeling in Rat Pulmonary Arterial Hypertension. Ji XY; Lei CJ; Kong S; Li HF; Pan SY; Chen YJ; Zhao FR; Zhu TT Drug Des Devel Ther; 2024; 18():475-491. PubMed ID: 38405578 [TBL] [Abstract][Full Text] [Related]
19. Naringin attenuates alcoholic liver injury by reducing lipid accumulation and oxidative stress. Zhou C; Lai Y; Huang P; Xie L; Lin H; Zhou Z; Mo C; Deng G; Yan W; Gao Z; Huang S; Chen Y; Sun X; Lv Z; Gao L Life Sci; 2019 Jan; 216():305-312. PubMed ID: 30031061 [TBL] [Abstract][Full Text] [Related]
20. Hydroxysafflor yellow A exerts antioxidant effects in a rat model of traumatic brain injury. Wang Y; Zhang C; Peng W; Xia Z; Gan P; Huang W; Shi Y; Fan R Mol Med Rep; 2016 Oct; 14(4):3690-6. PubMed ID: 27599591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]